|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Remark R, Becker C, Gomez JE, Damotte D,
Dieu-Nosjean MC, Sautès-Fridman C, Fridman WH, Powell CA, Altorki
NK, Merad M and Gnjatic S: The non-small cell lung cancer immune
contexture. A major determinant of tumor characteristics and
patient outcome. Am J Respir Crit Care Med. 191:377–390. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sundahl N and Lievens Y: Radiotherapy for
oligometastatic non-small cell lung cancer: A narrative review.
Transl Lung Cancer Res. 10:3420–3431. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Changizi V, Bahrami M, Esfahani M and
Shetab-Boushehri SV: Prevention of γ-radiation-induced DNA damage
in human lymphocytes using a serine-magnesium sulfate mixture.
Sultan Qaboos Univ Med J. 17:e162–e167. 2017.PubMed/NCBI
|
|
5
|
Wang Y, Huang J, Wu Q, Zhang J, Ma Z, Zhu
L, Xia B, Ma S and Zhang S: Decitabine sensitizes the
radioresistant lung adenocarcinoma to pemetrexed through
upregulation of folate receptor alpha. Front Oncol. 11:6687982021.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang Y, Chong Y, Chen M, Dai W, Zhou X, Ji
Y, Qiu G and Du X: Targeting lactate dehydrogenase a improves
radiotherapy efficacy in non-small cell lung cancer: From bedside
to bench. J Transl Med. 19:1702021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu LM, Yu H, Yuan YJ, Zhang J, Ma Y, Cao
XC, Wang J, Zhao LJ and Wang P: Overcoming of radioresistance in
non-small cell lung cancer by microRNA-320a through
HIF1α-suppression mediated methylation of PTEN. Front Cell Dev
Biol. 8:5537332020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li B, Cao Y, Sun M and Feng H: Expression,
regulation, and function of exosome-derived miRNAs in cancer
progression and therapy. FASEB J. 35:e219162021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: MicroRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wei T, Cheng S, Fu XN and Feng LJ:
MiR-219a-5p enhances the radiosensitivity of non-small cell lung
cancer cells through targeting CD164. Biosci Rep.
40:BSR201927952020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen X, Xu Y, Jiang L and Tan Q:
MiRNA-218-5p increases cell sensitivity by inhibiting PRKDC
activity in radiation-resistant lung carcinoma cells. Thorac
Cancer. 12:1549–1557. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xue T, Yin G, Yang W, Chen X, Liu C, Yang
W and Zhu J: MiR-129-5p promotes radio-sensitivity of NSCLC cells
by targeting SOX4 and RUNX1. Curr Cancer Drug Targets. 21:702–712.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Q, Wang Y, Dang H and Wu X:
MicroRNA-148a-3p inhibits the proliferation of cervical cancer
cells by regulating the expression levels of DNMT1 and UTF1. Oncol
Lett. 22:6172021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fu X, Hong L, Yang Z, Tu Y, Xin W, Zha M,
Tu S, Sun G, Li Y and Xiao W: MicroRNA-148a-3p suppresses
epithelial-to-mesenchymal transition and stemness properties via
Wnt1-mediated Wnt/β-catenin pathway in pancreatic cancer. J Cell
Mol Med. 24:13020–13035. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bao C and Guo L: MicroRNA-148a-3p inhibits
cancer progression and is a novel screening biomarker for gastric
cancer. J Clin Lab Anal. 34:e234542020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
He M and Xue Y: MicroRNA-148a suppresses
proliferation and invasion potential of non-small cell lung
carcinomas via regulation of STAT3. Onco Targets Ther.
10:1353–1361. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Joshi P, Jeon YJ, Laganà A, Middleton J,
Secchiero P, Garofalo M and Croce CM: MicroRNA-148a reduces
tumorigenesis and increases TRAIL-induced apoptosis in NSCLC. Proc
Natl Acad Sci USA. 112:8650–8655. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie Q, Yu Z, Lu Y, Fan J, Ni Y and Ma L:
MicroRNA-148a-3p inhibited the proliferation and
epithelial-mesenchymal transition progression of non-small-cell
lung cancer via modulating Ras/MAPK/Erk signaling. J Cell Physiol.
234:12786–12799. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TDP: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu L, Shang M, Song X, Zhang C and Guo W:
Fractionated irradiation enhances invasion and migration by
inducing epithelial-mesenchymal transition and stemness-like
properties in A549 cells. Ann Clin Lab Sci. 51:521–528.
2021.PubMed/NCBI
|
|
22
|
Xiong W and Hu XHW: AKR1C3 and β-catenin
expression in non-small cell lung cancer and relationship with
radiation resistance. J BUON. 26:802–811. 2021.PubMed/NCBI
|
|
23
|
Dai K, Chen L, Liu J, Ding Y, Gu C and Lu
X: MiR-147a mediated by sodium new houttuyfonate could enhance
radiosensitivity of non-small cell lung cancer cells via
suppressing STAT3. Adv Clin Exp Med. 30:173–181. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan Y, Liao H, Pu Q, Ke X, Hu X, Ma Y,
Luo X, Jiang Q, Gong Y, Wu M, et al: MiR-410 induces both
epithelial-mesenchymal transition and radioresistance through
activation of the PI3K/mTOR pathway in non-small cell lung cancer.
Signal Transduct Target Ther. 5:852020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun C, Zeng X, Guo H, Wang T, Wei L, Zhang
Y, Zhao J, Ma X and Zhang N: MicroRNA-125a-5p modulates
radioresistance in LTEP-a2 non-small cell lung cancer cells by
targeting SIRT7. Cancer Biomark. 27:39–49. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu B, Chen Z, Wang X, Chen F, Song Z and
Cao C: MicroRNA-148a-3p directly targets SERPINE1 to suppress
EMT-mediated colon adenocarcinoma progression. Cancer Manag Res.
13:6349–6362. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Elhelbawy NG, Zaid IF, Khalifa AA, Gohar
SF and Fouda EA: MiRNA-148a and miRNA-30c expressions as potential
biomarkers in breast cancer patients. Biochem Biophys Rep.
27:1010602021.PubMed/NCBI
|
|
28
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
